OTCMKTS:NMRD Nemaura Medical Q2 2024 Earnings Results & Report $0.0001 0.00 (0.00%) As of 11/9/2026 02:59 PM Eastern Nemaura Medical missed analyst earnings expectations in its Q2 2024 results, released November 13, 2023. The company reported EPS of -$0.11 versus the -$0.10 consensus estimate. Research:Profile Earnings Announcement Details QuarterQ2 2024Report DateNovember 13, 2023 Nemaura Medical EPS ResultsActual EPS-$0.11Consensus EPS -$0.10Beat/MissMissed by -$0.01One Year Ago EPSN/AEPS Beat Rate2 of last 8 quartersNemaura Medical Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsNemaura Medical's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile Nemaura Medical Q2 2024 Earnings FAQ Did Nemaura Medical beat earnings estimates for Q2 2024? Nemaura Medical (OTCMKTS:NMRD) reported earnings of -$0.11 per share for Q2 2024, missing the consensus estimate of -$0.10. The report was announced on Monday, November 13, 2023. When is Nemaura Medical's next earnings date? Nemaura Medical's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Nemaura Medical on the company's earnings history page. Nemaura Medical Earnings HeadlinesNMRD Nemaura Medical Inc.June 18, 2025 | seekingalpha.comNemaura Medical (OTC:NMRD) Stock Quotes, Forecast and News SummaryAugust 25, 2024 | benzinga.comThe Withdrawal You'll Never See on Your StatementA proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to deliberately weaken the US dollar, making American exports cheaper. For savers, a weaker dollar can quietly reduce purchasing power even if account balances stay the same. Bishop Gold Group's free 2026 Gold IRA Guide explains how physical gold can be held inside a retirement account, including a common rollover mistake that can trigger a taxable distribution.November 10 at 1:00 AM | Bishop Gold Group (Ad)Nemaura Medical Inc (NMRD)May 26, 2024 | investing.comNXNN Nexeon Medsystems IncMay 24, 2024 | seekingalpha.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 22, 2024 | finance.yahoo.comSee More Nemaura Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nemaura Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nemaura Medical and other key companies, straight to your email. Email Address About Nemaura MedicalNemaura Medical (OTCMKTS:NMRD), Inc. is a medical technology company focused on developing wearable solutions for diabetes and metabolic health monitoring. Its principal product is SugarBEAT, a non-invasive glucose monitoring system designed to provide continuous or periodic glucose readings without the need for traditional finger-stick testing. SugarBEAT is designed to use a disposable skin patch, a reusable sensor transmitter and a software application to collect and display glucose information. The company has also described applications for the technology in diabetes management, prediabetes monitoring and broader wellness programs. Nemaura Medical has pursued regulatory clearances and commercial opportunities in international markets, including the United Kingdom and Europe. The company is headquartered in Fremont, California. Public information about its current commercial operations, product availability and leadership may be limited, and the regulatory status of its products can vary by geography.View Nemaura Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A $4 Billion Jolt: NRG Energy Powers Data Center AmbitionsD-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneRocket Lab's Record Backlog Could Fuel a Rebound, But Neutron Raises the StakesDraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
